menu
    • menu

    Company profile for ProfoundBio

    NEW Drugs in Dev: 4
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aiming to help patients with cancer through the discovery and development of novel targeted therapeutics with curative potential. We are focused on discovering and advancing novel classes of therapeutics that are designed to leverage the immune system to eradicate cancer. For patients whose immune systems are insufficient to mount an anti-cancer response, we also develop therapeutics that delivery a small molecule payload spe...
    Aiming to help patients with cancer through the discovery and development of novel targeted therapeutics with curative potential. We are focused on discovering and advancing novel classes of therapeutics that are designed to leverage the immune system to eradicate cancer. For patients whose immune systems are insufficient to mount an anti-cancer response, we also develop therapeutics that delivery a small molecule payload specifically to tumor cells. Our team of experienced scientists take a fresh look at how to best eradicate cancer by taking an open, creativity approach to drug discovery.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ProfoundBioChina Flag
    Country
    Country
    China
    Address
    Address
    Suite 419, Building A4, 218 Xinghu Street, Suzhou Industrial Park, China 21512...
    Telephone
    Telephone
    +86-512-6799-1868
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.profoundbiosz.cn/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/profoundbio/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genmab Sheds Another Clinical ADC From $1.8B Profoundbio Buy
    Genmab Sheds Another Clinical ADC From $1.8B Profoundbio Buy

    17 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/genmab-sheds-another-clinical-adc-18b-profoundbio-buy

    FIERCE BIOTECH
    17 Nov 2025
    Share Share
    Genmab Discards ADC from $1.8 B ProfoundBio Buy
    Genmab Discards ADC from $1.8 B ProfoundBio Buy

    17 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/genmab-discards-clinical-adc-picked-last-years-18b-profoundbio-buy

    FIERCE BIOTECH
    17 Sep 2025
    Share Share
    Genmab Announces Financial Results for the First Half of 2024
    Genmab Announces Financial Results for the First Half of 2024

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2927105/0/en/Genmab-Announces-Financial-Results-for-the-First-Half-of-2024.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Genmab buys ProfoundBio for $1.8B
    Genmab buys ProfoundBio for $1.8B

    04 Jun 2024

    // PRESS RELEASE

    https://www.chemexpress.com/news-and-events/news/Exatecans

    PRESS RELEASE
    04 Jun 2024
    Share Share
    Genmab Completes Acquisition of ProfoundBio
    Genmab Completes Acquisition of ProfoundBio

    21 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/21/2885823/0/en/Genmab-Completes-Acquisition-of-ProfoundBio.html

    GLOBENEWSWIRE
    21 May 2024
    Share Share
    Genmab bulks ADC pipeline with $1.8-billion purchase of ProfoundBio
    Genmab bulks ADC pipeline with $1.8-billion purchase of ProfoundBio

    04 Apr 2024

    // GLOBENEWSWIRE

    https://ml-eu.globenewswire.com/Resource/Download/c4442fee-72fd-4922-b334-504a4ab313aa

    GLOBENEWSWIRE
    04 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search